Negative and positive regulation of MAPK phosphatase 3 controls platelet-derived growth factor-induced Erk activation. - Wikidata - awgldk - TriplyDB

Negative and positive regulation of MAPK phosphatase 3 controls platelet-derived growth factor-induced Erk activation.

Negative and positive regulation of MAPK phosphatase 3 controls platelet-derived growth factor-induced Erk activation.

http://www.wikidata.org/entity/Q39902129

about

Simultaneous visualization of both signaling cascade activity and end-point gene expression in single cells p-MAPK1/3 and DUSP6 regulate epididymal cell proliferation and survival in a region-specific manner in mice.Systematic quantification of negative feedback mechanisms in the extracellular signal-regulated kinase (ERK) signaling network.Dual specificity phosphatase 6 (DUSP6) is an ETS-regulated negative feedback mediator of oncogenic ERK signaling in lung cancer cells.FOXO1-dependent up-regulation of MAP kinase phosphatase 3 (MKP-3) mediates glucocorticoid-induced hepatic lipid accumulation in mice Differential up-regulation of MAP kinase phosphatases MKP3/DUSP6 and DUSP5 by Ets2 and c-Jun converge in the control of the growth arrest versus proliferation response of MCF-7 breast cancer cells to phorbol ester.Targeting the PDGF signaling pathway in tumor treatment Systemic perturbation of the ERK signaling pathway by the proteasome inhibitor, MG132.NR4A1 promotes PDGF-BB-induced cell colony formation in soft agar Comparative microRNA profiling of sporadic and BRCA1 associated basal-like breast cancers.p38γ Mitogen-activated protein kinase signals through phosphorylating its phosphatase PTPH1 in regulating ras protein oncogenesis and stress response.Nickel nanoparticles enhance platelet-derived growth factor-induced chemokine expression by mesothelial cells via prolonged mitogen-activated protein kinase activation Protein kinase Cdelta supports survival of MDA-MB-231 breast cancer cells by suppressing the ERK1/2 pathway.The dual-specificity MAP kinase phosphatases: critical roles in development and cancer.Post-transcriptional regulation of the Ras-ERK/MAPK signaling pathway.Platelet-derived growth factor signaling in the lung. From lung development and disease to clinical studies.Exercise training decreases mitogen-activated protein kinase phosphatase-3 expression and suppresses hepatic gluconeogenesis in obese mice.Impact of oncogenic driver mutations on feedback between the PI3K and MEK pathways in cancer cells.BAG3 controls angiogenesis through regulation of ERK phosphorylation.DARPP-32 is required for MAPK/ERK signaling in thyroid cells.Signal integration and coincidence detection in the mitogen-activated protein kinase/extracellular signal-regulated kinase (ERK) cascade: concomitant activation of receptor tyrosine kinases and of LRP-1 leads to sustained ERK phosphorylation via dow Negative regulation of TGFβ signaling by the kinase LKB1 and the scaffolding protein LIP1.Assessment of SRM, MRM(3) , and DIA for the targeted analysis of phosphorylation dynamics in non-small cell lung cancer.MEK/ERK pathway mediates insulin-promoted degradation of MKP-3 protein in liver cells.Dual specificity phosphatase 5 and 6 are oppositely regulated in human skeletal muscle by acute exercise.Expression of protein-tyrosine phosphatases in Acute Myeloid Leukemia cells: FLT3 ITD sustains high levels of DUSP6 expression.Involvement of platelet-derived growth factor ligands and receptors in tumorigenesis.P2X7 Nucleotide and EGF Receptors Exert Dual Modulation of the Dual-Specificity Phosphatase 6 (MKP-3) in Granule Neurons and Astrocytes, Contributing to Negative Feedback on ERK Signaling.Identification of potentially critical differentially methylated genes in nasopharyngeal carcinoma: A comprehensive analysis of methylation profiling and gene expression profiling.Prognostic value of dual-specificity phosphatase 6 expression in non-small cell lung cancer.Dual-specificity phosphatase 6 (DUSP6): a review of its molecular characteristics and clinical relevance in cancer.Angiogenesis: Managing the Culprits behind Tumorigenesis and Metastasis

P2860

Q28744297-40C93C5A-72E3-4338-91B0-290CC695C23D Q30429887-4FBF65EF-6E9F-47B3-BA7B-91BDAEF762B8 Q30497351-B0DFFD5B-B31F-4BDA-BD31-118D795FB5AF Q33759715-2AD2C4C7-7FD3-43FD-8D5E-B54C7C9280E6 Q34036204-451F2B55-32ED-4780-AB16-8B37B338A939 Q34074438-85F88615-A288-4564-99B7-8CF804231404 Q34393461-BDBDF325-F5AC-4CB4-A6BD-13705C5F6F33 Q34506190-B318A7A6-46AB-497D-9243-7BF87622A30D Q35289103-3FCCC0A1-E1FC-4D0D-987F-26413AA8323A Q35685370-8A193B99-E0D9-4990-9A65-1D8A9D264B2F Q36201947-BF53182F-59C9-4866-8561-48E7ADBA708C Q36369956-863F45E7-8215-454E-9E12-547D4B4C1654 Q37446199-37B773D4-18E4-4604-8F02-861E179F2A9E Q37750129-87E6E89F-F75C-4C27-BF50-F09DF94B9775 Q37891908-9196589D-5269-4A97-A6E0-44E4D097ED81 Q38258904-0323FC2C-8381-42D5-9296-39AE447F4446 Q38309913-E89C2177-47DE-4B0A-8FC2-1FF04AEAB3F8 Q39336729-570B68D7-86E9-4C09-AF0E-46DCB9F2A350 Q39400810-3295AB54-0568-441C-B97F-19816D8E4E8F Q39402299-01A47E12-51F5-4C49-B896-54AB80F8C079 Q39537040-B6051C83-7FC7-4A6D-87BC-56D5EFA1B17C Q39640020-13EFFAEC-90DB-4269-94A6-12FF1047CCF8 Q39739968-2D6D8115-E241-41B8-8AE8-873ECF056D44 Q41965431-EDC21CEB-065A-43EF-8CFC-ECD600C4DBFE Q42378109-4A9226C1-BA1F-46F1-916E-4646F52B0497 Q42515217-15D1BEF4-1576-40E9-9646-928119691208 Q47756210-82E08717-E50E-40B8-9A02-A9590BAED676 Q49205265-1760BCAB-70BA-495C-8603-37357426AC46 Q49986892-5F75E8DC-7829-41C5-A27E-B339D7FD6CFE Q50619584-D774B531-7A74-408E-A093-2E5ED03F5AF4 Q53177105-C9020B7F-C0FB-4F14-A0AF-E8649D779A6C Q57825996-106121FB-7850-4935-B5DF-E993E45D5651

P2860

Negative and positive regulation of MAPK phosphatase 3 controls platelet-derived growth factor-induced Erk activation.

http://www.wikidata.org/entity/Q39902129

description

2008 nî lūn-bûn

@nan

2008年の論文

@ja

2008年学术文章

@wuu

2008年学术文章

@zh-cn

2008年学术文章

@zh-hans

2008年学术文章

@zh-my

2008年学术文章

@zh-sg

2008年學術文章

@yue

2008年學術文章

@zh

2008年學術文章

@zh-hant

name

Negative and positive regulati ...... factor-induced Erk activation.

@en

Negative and positive regulati ...... factor-induced Erk activation.

@nl

type

label

Negative and positive regulati ...... factor-induced Erk activation.

@en

Negative and positive regulati ...... factor-induced Erk activation.

@nl

prefLabel

Negative and positive regulati ...... factor-induced Erk activation.

@en

Negative and positive regulati ...... factor-induced Erk activation.

@nl

P1433

Q39902129-9CA1FB54-7081-422D-8D3D-E9556B3240BF

P1476

Q39902129-AB285CEA-8C6B-4737-A3B9-F1088290D7AC

P2093

Q39902129-053E5347-9508-44CB-9156-47CD72CE84EF

Q39902129-5716A9A9-CD5C-40CF-906B-7E8C24DA7E8C

Q39902129-C504BD18-F37B-4758-A780-E4A355C469E2

Q39902129-C8D7C581-D85D-472F-A524-0AAAD546C50C

Q39902129-D56A3B5F-FBEE-4024-9460-8DC7C71A1A48

P2860

Q39902129-032A2AA6-414D-4221-95EC-870F0B0D8E9A

Q39902129-1194994C-2A62-4462-8671-0E27ED7FAFA0

Q39902129-18E3DFB2-C005-4D5F-95B4-4D3666C03703

Q39902129-273EE2BA-6927-4D45-9512-46DB042A9688

Q39902129-2D20A277-0077-4FBF-A6A4-70D13DEAE1EF

Q39902129-2E80C68C-CE03-480E-B1A4-8EC3A518A708

Q39902129-7FAD0E7B-864A-4AA4-A749-954B136005C1

Q39902129-92C06C0E-2E5D-487E-920B-004E84A9F9A6

Q39902129-9F439953-83EB-49B2-8D4F-8539A09BA79C

Q39902129-B0487C76-EC7B-4616-B2CD-8E5AFB265E27

P304

Q39902129-5FDF113C-CBB1-47C7-AE63-7CF4C50FDB09

P31

Q39902129-BE7A0351-93F3-469E-905E-2D06D66825E4

P356

Q39902129-18403FCE-C952-4BAD-8D20-1FB0165A1B01

P407

Q39902129-89E2B77E-09D1-46BD-B3BB-7ED7C6BA2517

P433

Q39902129-7A3ED773-C144-4A32-9609-779F205070DF

P478

Q39902129-91E1AD93-9CEE-450B-84AC-6A653156D352

P577

Q39902129-AE1F6FD3-7615-4B33-A279-45CE5A25084D

P698

Q39902129-9BB9D5B1-3B84-4564-A138-598A75DD4A72

P356

P1433

Journal of Biological Chemistry

P1476

Negative and positive regulati ...... factor-induced Erk activation.

@en

P2093

Agnieszka Gembarska

http://www.w3.org/2001/XMLSchema#string

Aleksandra Jurek

http://www.w3.org/2001/XMLSchema#string

Carl-Henrik Heldin

http://www.w3.org/2001/XMLSchema#string

Johan Lennartsson

http://www.w3.org/2001/XMLSchema#string

Kenichi Amagasaki

http://www.w3.org/2001/XMLSchema#string

P2860

Reduced MAP kinase phosphatase-1 degradation after p42/p44MAPK-dependent phosphorylation

Cooperation of ERK and SCFSkp2 for MKP-1 destruction provides a positive feedback regulation of proliferating signaling

Specific inactivation and nuclear anchoring of extracellular signal-regulated kinase 2 by the inducible dual-specificity protein phosphatase DUSP5

Extracellular signal-regulated kinases phosphorylate mitogen-activated protein kinase phosphatase 3/DUSP6 at serines 159 and 197, two sites critical for its proteasomal degradation

Protein modules and signalling networks

Identification of the major phosphorylation sites for protein kinase C in kit/stem cell factor receptor in vitro and in intact cells

Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-regulated kinase activation

Mammalian MAP kinase signalling cascades

MKP-3, a novel cytosolic protein-tyrosine phosphatase that exemplifies a new class of mitogen-activated protein kinase phosphatase

Constitutive activation of the 41-/43-kDa mitogen-activated protein kinase signaling pathway in human tumors

P304

4626-4634

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1074/JBC.M808490200

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

284

http://www.w3.org/2001/XMLSchema#string

P577

2008-12-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19106095

http://www.w3.org/2001/XMLSchema#string